SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $580,521,914 |
| Positions | 84 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| TANGO THERAPEUTICS INC | TNGX | COM | $38,231,574 | 1,223,019 |
| ABIVAX SA | ABVX | SPONSORED ADS | $37,800,132 | 283,657 |
| REVOLUTION MEDICINES INC | RVMD | COM | $29,954,125 | 159,943 |
| ERASCA INC | ERAS | COM | $28,687,526 | 1,565,913 |
| TYRA BIOSCIENCES INC | TYRA | COM | $20,210,163 | 632,754 |
| DIANTHUS THERAPEUTICS INC | DNTH | COM | $19,578,955 | 200,851 |
| ENLIVEN THERAPEUTICS INC | ELVN | COM | $17,605,886 | 346,914 |
| MINERALYS THERAPEUTICS INC | MLYS | COM | $16,260,468 | 602,686 |
| BIOHAVEN LTD | BHVN | COM | $15,835,296 | 1,064,200 |
| SURROZEN INC | SRZN | COM NEW | $13,786,568 | 602,798 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.